Stock LUPIN LUPIN LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

All News Lupin Limited

Equities

LUPIN

INE326A01037

Market Closed - Bombay S.E.
Other stock markets
 06:00:53 2024-06-10 am EDT 		5-day change 1st Jan Change
1,636 INR +0.43% Intraday chart for Lupin Limited +3.04% +23.67%
Jun. 05 Lupin Arm Acquires Two Brands from Sanofi in Europe and Canada MT
May. 30 India's pharma export sales to grow faster this year, trade body says RE

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Lupin : June 5, 2024 Lupin Completes Acquisition of two Brands from Sanofi in Europe and Canada
PU
Lupin Arm Acquires Two Brands from Sanofi in Europe and Canada
MT
Lupin : June 3, 2024 Lupin Receives Tentative Approval from U.S. FDA for Letermovir Tablets
PU
Lupin : June 3, 2024 Lupin Launches Doxycycline for Injection USP in the United States
PU
India's pharma export sales to grow faster this year, trade body says
RE
Indian drugmakers to see FY25 revenue boost in key US market, says India Ratings and Research
RE
Lupin Gets Six Observations from US FDA After Somerset Unit Inspection
MT
U.S. FDA Concludes a Pre Approval Inspection at Lupin's Somerset, New Jersey Manufacturing Facility
CI
Lupin : May 16, 2024 Lupin Receives Approval from U.S. FDA for Midostaurin Capsules
PU
Lupin : May 15, 2024 Lupin Achieves Significant Milestone with ISO 14001 and ISO 45001 Certification Across All its Indian Manufacturing Sites, R&D Center and Corporate Office
PU
Lupin Relaunches Mirabegron ER Tablets in US
MT
Nomura Adjusts Lupin’s Price Target to INR1,952 From INR1,949, Keeps at Buy
MT
Lupin : May 9, 2024 Jeffrey Kindler and Alfonso Zulueta Join Lupin Board as Independent Directors
PU
Lupin Limited Announces Board Appointments
CI
Jefferies Adjusts Lupin’s Price Target to INR1,535 From INR1,460 Keeps at Hold
MT
Transcript : Lupin Limited, Q4 2024 Earnings Call, May 07, 2024
Lupin's Consolidated Profit Climbs in Fiscal Q4; Shares Dip 4%
MT
Indian drugmaker Lupin misses quarterly profit estimates as costs rise
RE
Lupin : May 6, 2024 Lupin Receives Approval from U.S. FDA for Travoprost Ophthalmic Solution USP
PU
Lupin Limited Board Recommends Dividend for the Year Ended March 31, 2024
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LUPIN Stock
  4. News Lupin Limited